124 related articles for article (PubMed ID: 37347259)
1. Factors affecting participation in the colorectal cancer screening program: a cross-sectional population study.
Romanová A; Lustigová M; Urbanová J; Keil R; Krollová P; Šťovíček J; Wasserbauer M; Hlava Š; Malinovská J; Drábek J; Brož J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11135-11143. PubMed ID: 37347259
[TBL] [Abstract][Full Text] [Related]
2. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
3. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
Nielsen JB; Berg-Beckhoff G; Leppin A
BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
[TBL] [Abstract][Full Text] [Related]
4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
6. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
[TBL] [Abstract][Full Text] [Related]
7. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
8. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
[TBL] [Abstract][Full Text] [Related]
10. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
11. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
12. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
[No Abstract] [Full Text] [Related]
13. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
14. [The populations attitudes to colorectal cancer screening in the Czech Republic].
Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
[TBL] [Abstract][Full Text] [Related]
15. Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study.
Schult AL; Botteri E; Hoff G; Randel KR; Dalén E; Eskeland SL; Holme Ø; de Lange T
BMJ Open; 2021 Jul; 11(7):e048183. PubMed ID: 34210732
[TBL] [Abstract][Full Text] [Related]
16. Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2021 Dec; 28(4):439-447. PubMed ID: 34106777
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
18. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
19. Participation and yield of a population-based colorectal cancer screening programme in China.
Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
[TBL] [Abstract][Full Text] [Related]
20. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]